title: Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
authors.affiliation: UAB Comprehensive Cancer Center, Birmingham, AL.
authors.forename: Guru
authors.initials: G
authors.lastname: Sonpavde
authors.affiliation: University Hospital del Mar-IMIM, Barcelona, Spain.
authors.forename: Joaquim
authors.initials: J
authors.lastname: Bellmunt
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Jonathon E
authors.initials: JE
authors.lastname: Rosenberg
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Ashley M
authors.initials: AM
authors.lastname: Regazzi
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Dean F
authors.initials: DF
authors.lastname: Bajorin
authors.affiliation: Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
authors.forename: Toni K
authors.initials: TK
authors.lastname: Choueiri
authors.affiliation: Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
authors.forename: Angela Q
authors.initials: AQ
authors.lastname: Qu
authors.affiliation: Heinrich Heine University, Dusseldorf, Germany.
authors.forename: Guenter
authors.initials: G
authors.lastname: Niegisch
authors.affiliation: Heinrich Heine University, Dusseldorf, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Albers
authors.affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Necchi
authors.affiliation: University Federico II, Naples, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Di Lorenzo
authors.affiliation: Institut de Recherche Pierre Fabre, Boulogne, France.
authors.forename: Ronan
authors.initials: R
authors.lastname: Fougeray
authors.affiliation: Fox Chase Cancer Center, Philadelphia, PA.
authors.forename: Yu-Ning
authors.initials: YN
authors.lastname: Wong
authors.affiliation: Princess Margaret Hospital, Toronto, ON, Canada.
authors.forename: Srikala S
authors.initials: SS
authors.lastname: Sridhar
authors.affiliation: Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
authors.forename: Yoo-Joung
authors.initials: YJ
authors.lastname: Ko
authors.affiliation: University of North Carolina, Chapel Hill, NC.
authors.forename: Matthew I
authors.initials: MI
authors.lastname: Milowsky
authors.affiliation: Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Galsky
authors.affiliation: McMaster University, Hamilton, ON, Canada.
authors.forename: Gregory R
authors.initials: GR
authors.lastname: Pond
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D018579:Patient Selection; D012107:Research Design; D016879:Salvage Therapy / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents